TAP Biosystems in Cambridge and University College London in the UK are collaborating to develop a new technology weapon designed to fight cancer.
Only an interdisciplinary approach by the scientific research community will solve the growing problem of disease in an ageing population, a Cambridge UK technology summit was warned.
Personalised medicines pioneer Horizon Discovery has developed a new weapon in the fight against ‘undruggable’ cancer genes.
Cambridge UK healthcare technology specialist How are you? has launched a new app store with The European Directory of Health Apps 2012-2013 – claiming the first-ever directory and app store of its kind.
Cancer drug discovery business, Sareum, saw its losses deepen in the year to June 30 but the Cambridge UK company believes its first big deal is just around the corner.
A Cambridge UK pharmaceutical company has reported positive results from a new study into preventing acute nausea and vomiting in cancer patients.
Endomagnetics, the Cambridge UK company developing technology to improve the standard of breast cancer management, has achieved certification to an international quality standard.
Cambridge drug delivery business Vectura is set to collect a $10 million windfall from Novartis and earn subsequent royalty streams following a key approval for pioneering inhaler technology.
- MedImmune-AZ-Roche form personalised medicines axis
- Vectura lands £2.5m Japan windfall
- BioFocus expands in Cambridge
- Lightning strikes for Innova in Canada
- Personalised cancer treatment breakthrough
- Cambridge misses out on US medical mission
- Sphere Medical first half losses doubled
- €1m Servier oncology milestone for Vernalis
- Cambridge spin-out BlueGnome acquired by Illumina
- Demand spirals for nasal spray innovation
- New antibody to revolutionise drug discovery
- Cannabis discovery hope for epilepsy treatment
Page 52 of 122